BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34378186)

  • 1. Alpha haemoglobin-stabilising protein concentration in the red blood cells of patients with sickle cell anaemia with and without hydroxycarbamide treatment.
    Vasseur C; Domingues-Hamdi E; Pakdaman S; Galactéros F; Baudin-Creuza V
    Br J Haematol; 2022 Jan; 196(1):183-192. PubMed ID: 34378186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).
    Wang WC; Ware RE; Miller ST; Iyer RV; Casella JF; Minniti CP; Rana S; Thornburg CD; Rogers ZR; Kalpatthi RV; Barredo JC; Brown RC; Sarnaik SA; Howard TH; Wynn LW; Kutlar A; Armstrong FD; Files BA; Goldsmith JC; Waclawiw MA; Huang X; Thompson BW;
    Lancet; 2011 May; 377(9778):1663-72. PubMed ID: 21571150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Haemoglobin stabilising protein expression is influenced by mean cell haemoglobin and HbF levels in HbE/β-thalassaemia individuals.
    Lim WF; Muniandi L; George E; Sathar J; Teh LK; Gan GG; Lai MI
    Blood Cells Mol Dis; 2012 Jan; 48(1):17-21. PubMed ID: 22079025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of hydroxycarbamide on the plasma proteome of children with sickle cell anaemia.
    Brewin J; Tewari S; Menzel S; Kirkham F; Inusa B; Renney G; Ward M; Rees DC
    Br J Haematol; 2019 Sep; 186(6):879-886. PubMed ID: 31140594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic human alpha-hemoglobin stabilizing protein could partially relieve betaIVS-2-654-thalassemia syndrome in model mice.
    Wang B; Fang Y; Guo X; Ren Z; Zhang J
    Hum Gene Ther; 2010 Feb; 21(2):149-56. PubMed ID: 20063986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of alpha hemoglobin stabilizing protein expression in patients with β thalassemia and sickle cell anemia and its impact on clinical severity.
    Mahmoud HM; Shoeib AA; Abd El Ghany SM; Reda MM; Ragab IA
    Blood Cells Mol Dis; 2015 Dec; 55(4):358-62. PubMed ID: 26460260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alpha-hemoglobin stabilizing protein and expression of unstable alpha-Hb variants.
    Vasseur C; Domingues-Hamdi E; Brillet T; Marden MC; Baudin-Creuza V
    Clin Biochem; 2009 Dec; 42(18):1818-23. PubMed ID: 19482015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia.
    Flanagan JM; Steward S; Howard TA; Mortier NA; Kimble AC; Aygun B; Hankins JS; Neale GA; Ware RE
    Br J Haematol; 2012 Apr; 157(2):240-8. PubMed ID: 22360576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxycarbamide reduces eosinophil adhesion and degranulation in sickle cell anaemia patients.
    Pallis FR; Conran N; Fertrin KY; Olalla Saad ST; Costa FF; Franco-Penteado CF
    Br J Haematol; 2014 Jan; 164(2):286-95. PubMed ID: 24383847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An abundant erythroid protein that stabilizes free alpha-haemoglobin.
    Kihm AJ; Kong Y; Hong W; Russell JE; Rouda S; Adachi K; Simon MC; Blobel GA; Weiss MJ
    Nature; 2002 Jun; 417(6890):758-63. PubMed ID: 12066189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease of externalized phosphatidylserine density on red blood cell-derived microparticles in SCA patients treated with hydroxycarbamide.
    Garnier Y; Ferdinand S; Connes P; Garnier M; Etienne-Julan M; Lemonne N; Romana M
    Br J Haematol; 2018 Aug; 182(3):448-451. PubMed ID: 28653368
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the free α-hemoglobin pool in red blood cells: a new test providing a scale of β-thalassemia severity.
    Vasseur C; Pissard S; Domingues-Hamdi E; Marden MC; Galactéros F; Baudin-Creuza V
    Am J Hematol; 2011 Feb; 86(2):199-202. PubMed ID: 21264907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Hemoglobin stabilizing protein: a modulating factor in thalassemias?
    Wajcman H; Vasseur C; Pissard S; Baudin-Creuza V
    Hemoglobin; 2011; 35(5-6):463-8. PubMed ID: 21950764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised controlled provider-blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherence.
    Smith WR; McClish DK; Lottenberg R; Sisler IY; Sop D; Johnson S; Villella A; Liles D; Yang E; Chen I
    Br J Haematol; 2022 Jan; 196(1):193-203. PubMed ID: 34786695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiles of erythroid precursors characterise several mechanisms of the action of hydroxycarbamide in sickle cell anaemia.
    Costa FC; da Cunha AF; Fattori A; de Sousa Peres T; Costa GG; Machado TF; de Albuquerque DM; Gambero S; Lanaro C; Saad ST; Costa FF
    Br J Haematol; 2007 Jan; 136(2):333-42. PubMed ID: 17156400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic organisation and regulation of murine alpha haemoglobin stabilising protein by erythroid Kruppel-like factor.
    Keys JR; Tallack MR; Hodge DJ; Cridland SO; David R; Perkins AC
    Br J Haematol; 2007 Jan; 136(1):150-7. PubMed ID: 17069580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An erythroid chaperone that facilitates folding of alpha-globin subunits for hemoglobin synthesis.
    Yu X; Kong Y; Dore LC; Abdulmalik O; Katein AM; Zhou S; Choi JK; Gell D; Mackay JP; Gow AJ; Weiss MJ
    J Clin Invest; 2007 Jul; 117(7):1856-65. PubMed ID: 17607360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AHSP (α-haemoglobin-stabilizing protein) stabilizes apo-α-haemoglobin in a partially folded state.
    Krishna Kumar K; Dickson CF; Weiss MJ; Mackay JP; Gell DA
    Biochem J; 2010 Dec; 432(2):275-82. PubMed ID: 20860551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal and myocardial microvascular blood flow in hydroxycarbamide-treated patients with sickle cell disease.
    Sachdev V; Sidenko S; Wu MD; Minniti CP; Hannoush H; Brenneman CL; Waclawiw MA; Arai AE; Schechter AN; Kato GJ; Lindner JR
    Br J Haematol; 2017 Nov; 179(4):648-656. PubMed ID: 28880374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inheritance of the Bantu/Benin haplotype causes less severe hemolytic and oxidative stress in sickle cell anemia patients treated with hydroxycarbamide.
    Okumura JV; Silva DG; Torres LS; Belini-Junior E; Barberino WM; Oliveira RG; Carrocini GC; Gelaleti GB; Lobo CL; Bonini-Domingos CR
    J Hum Genet; 2016 Jul; 61(7):605-11. PubMed ID: 26961071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.